Sağlıklı Bireylerde ve Kognitif Etkilenmesi Olanlarda Kokusal ve Görsel Elektrofizyolojik İncelemelerin Tanıya Katkısı ve Nöropsikolojik Test Sonuçlarıyla İlişkisi

Year 2019, Volume: 6 Issue: 2, 86 - 91, 29.08.2019

Mehmet Tayfun Kaşıkcı

Abstract

Çalışmamıza unutkanlık yakınması tanımlayan ya da bu yakınma ile getirilen 45 olgu ile yakınması olmayan ve nörolojik muayeneleri normal bulunan 39 olgu alınmış ve olguların tümünde GATA Haydarpaşa Eğitim Hastanesi Nöroloji Servisi Nöropsikolojik Test Bataryası, Koku Tarama Testi, Normal ve Koku ile aktive edilmiş EEG, Görsel Uyandırılmış Yanıtlar ile Olaya İlişkin Potansiyel incelemeleri gerçekleştirilmiştir. Koku Tarama Testinde normal olgularda ortalama koku skoru 8 ve alt sınırı 5 olarak bulunmuş, koku skorları ile yaş ve nöropsikolojik incelemeler arasında anlamlı ilişki saptanmıştır. Koku skorlarının hasta grupları ile karşılaştırılmalarında elde edilen sonuçlar anlamlı bulunmuştur. EEG incelemelerinde gerek normal gerekse hasta gruplarında özgün anormallikler saptanmamış ve çoğunluğunda normal EEG bulguları saptanmıştır. Ancak koku uyaranı ile birlikte anormal EEG oranlarında artma izlenmiş ve artış özellikle kötü koku uyarımında belirginleşmiştir. Görsel Uyandırılmış Yanıt Çalışması binoküler olarak gerçekleştirilmiş ve normal olgular ile hastalarda saptanan belirgin anormallik P100 genliğinde düşme olmuştur. P100 genliği ile koku skorları ve yaş arasında normal olgularda anlamlı ilişki saptanmış, hastalarda ise bu ilişki saptanmamıştır. Olaya İlişkin Potansiyel incelemelerinde normal inceleme sonrası ayrıca kokusal uyaran uygulanmış ve belirgin anormallik olarak normal olgularla kıyaslandığında P3 genliğinde düşme, Alzheimer Hastalığı grubunda ise P3 latansında uzama saptanmıştır. Özellikle kötü koku uyaranında benzer bulguların belirginleştiği gözlenmiştir. Çalışma sonucunda klinik ve elektrofizyolojik olarak kognitif bozuklukların değerlendirilmesinde yaptığımız testlerin geliştirilerek uygulanmasının yararlı olacağı kanısı oluşmuştur.

Keywords

Kognitif Etkilenme, Koku Tanıma, Olaya İlişkin Potansiyeller

Thanks

Makale hazırlama ve uzmanlık eğitimi süreci içerisinde sınırsız desteği ve katkısından dolayı sayın hocam Prof.Dr.Mehmet SARAÇOĞLU'na teşekkür ederim.

The Contribution of Olfactive and Visual Electrophysiological Tests to Diagnosis in Healthy and Cognitively Affected Individuals and its Relation to Nerophyschological Test Results

Abstract

This study includes 45 patients with memory complaints and 39 normal subjects. All participants were examined with neuropsychological test battery, smell identification test, EEG, olfactor evoked EEG, visual evoked responses and event related potential studies. Mean score in smell identification test was 8 and cut off score was 5. There was significant relation between smell scores and neuropsychological test scores. Significant results were found in the patient group. In EEG examination, spesific abormalities were detected neither in normal nor patient groups and majority of the EEGs were normal. However smell stimulation increased the rate of abnormal EEG findings where the noxius smells especially increased the abnormality rate. Visual evoked response study performed as binocular and major abnormality between the patients and normal subjects was decrease in the P100 amplitudes. In the normal subjects, there were significant relationships between the amplitude of the P100 waves and smell scores and age although it was not observed in the patient group. In the event related potential studies olfactor stimulation was performed after routine examination and main abnormality was found as decrease in the P3 amplitude in the patient groups. In the Alzheimer patients group there was increase in the latency of P3 wave. Noxius smells strengthened these findings. As a conclusion in the evaluation of the cognitive disorders such procedures may be useful and may provide additional information.

References

• 1. Petersen RC, Stevens J, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56(9):1133-42.
• 2. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Int Med. 2004;256(3):183-94.
• 3. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging. 1997;18(4):351-57.
• 4. Hyman BT. The neuropathological diagnosis of Alzheimer’s disease: clinical-pathological studies. Neurobiol Aging. 1997;8(4 Suppl):27-32.
• 5. Koss E, Weiffenbach JM, Haxby JV, Friedland RP. Olfactory detection and recognition in Alzheimer’s disease. Lancet. 1987;1(8533):622.
• 6. Djordjevic J, Jones-Gotman M, De Sousa K, Chertkow H. Olfaction in patients with mild cognitive impairment and Alzheimer's disease. Neurobiol Aging. 2008;29(5):693-706.
• 7. Jeong J. EEG Dynamics in patients with Alzheimer’s disease. Clin Neurophysiol. 2004;115(7):1490-505.
• 8. Brodie EE, Allan D, Brooks DN, McCulloch J, Foulds WS. Flash and pattern reversal visual evoked responses in normal and demented elderly. Cortex. 1992;28(2):289-93.
• 9. Polich J, Ehlers CL, Otis S, Mandell AJ, Bloom FE. P300 latency reflects the degree of cognitive decline in dementing illness. Electroencephalogr Clin Neurophysiol. 1986;63(2):138-44.
• 10. Serby M, Corwin J, Novatt A, Conrad P, Rotrosen J. Olfaction in dementia. J Neurol Neurosurg Psychiatry. 1985;48(8):848-49.
• 11. Murphy C, Bacon AW, Bondi MW, Salmon DP. Apolipoprotein E status is associated with odor identification deficits in “normal” older persons. Ann NY Acad Sci. 1998;855:744-50.
• 12. Nordin S, Murphy C. Impaired sensory and cognitive olfactory function in questionable Alzheimer’s disease. Neuropsychology. 1996;10(1):113-19.
• 13. Campanella S, Rossignol M, Mejias S, Joassin, F, Maurage P. Human gender differences in an emotional visual oddball task: an event-related potentials study. Neurosci Lett. 2004;367(1):14-18.
• 14. Bacon AW, Bondi MW, Salmon DP, Murphy C. Very early changes in olfactory functioning due to Alzheimer’s disease and the role of Apolipoprotein E in olfaction. Ann NY Acad Sci. 1998;855:723-31.
• 15. Schiffman SS, Graham BG, Sattely-Miller EA, Zervakis J, Welsh-Bojmer K. Taste, smell and neuropsychological performance of individuals at risk for Alzheimer’s disease. Neurobiol Aging. 2002;23(3):397-404.
• 16. Knott V, Mohr E, Mahoney C, Ilivitsky V. Quantitative electroencephalography in Alzheimer's disease: comparison with a control group, population norms and mental status. J Psychiatry Neurosci. 2001;26(2):106-16.
• 17. Kawas CH, Corrada MM, Brookmeyer R, et al. Visual memory predicts Alzheimer's disease more than a decade before diagnosis. Neurology. 2003;60(7):1089-93.
• 18. Kergoat H, Kergoat MJ, JustinoL, Chertkow H, Robillard A, Bergman H. Visual retinocortical function in dementia of the Alzheimer type. Gerontology. 2002;48(4):197-203.
• 19. Philpot MP, Amin D, Levy R. Visual evoked potentials in Alzheimer's disease: correlations with age and severity. Electroencephalogr Clin Neurophysiol. 1990;77(5):323-29.
• 20. Martinelli V, Locatelli T, Comi G, et al. Pattern visual evoked potential mapping in Alzheimer's disease: correlations with visuospatial impairment. Dementia. 1996;7(2):63-68.
• 21. Wetter S, Polich J, Murphy C. Olfactory, auditory, and visual ERPs from single trials: no evidence for habituation. Int Jour Psychophysiol. 2004;54(3):263-72.
• 22. Gonsalvez CJ, Polich J. P300 amplitude is determined by target-to-target interval. Psychophysiology. 2002;39(3):388-96.
• 23. Candan H, Poyrazoğlu E, Saraçoğlu M, et al. Normal olgularda kokusal uyandırılmış potansiyeller ve koku uyarımı ile EEG incelemeleri. KBB İhtisas Dergisi. 1997;4(3):151.
• 24. Saito M, Ishida T. Cognitive resource model for the information-processing of task-irrelevant visual stimuli. Psychiatry and Clin Neurosci. 2002;56(2):145-51.
• 25. Saito H, Yamazaki H, Matsuoka H, et al. Visual event-related potential in mild dementia of the Alzheimer’s type. Psychiatr Clin Neurosci. 2001;55(4):365-71.
• 26. Ito J. Somatosensory event-related potentials (ERPs) in patients with different types of dementia. J Neurol Sci. 1994;121(2):139-46.
• 27. Goodin DS, Squires KC, Henderson BH, Starr A. Age-related variations in evoked potentials to auditory stimuli in normal human subjects. Electroencephalogr Clin Neurophysiol. 1978; 44(4):447-58.
• 28. Lorig TS. The application of electroencephalographic techniques to the study of human olfaction: a review and tutorial. Int J Psychophysiol. 2000;36(2):91-104.
• 29. Wetter S, Murphy C. Individuals with Down’s syndrome demonstrate abnormal olfactory event-related potentials. Clin Neurophysiol. 1999;110(9):1563-69.
• 30. Wetter S, Murphy C. Apolipoprotein E epsilon4 positive individuals demonstrate delayed olfactory event-related potentials. Neurobiol Aging. 2001; 22(3):439-47.
• 31. Geisler MW, Murphy C. Event-related brain potentials to attended and ignored olfactory and trigeminal stimuli. Int J Psychophysiol. 2000;37(3):309-15.
• 32. Morgan CD, Murphy C. Olfactory event-related potentials in Alzheimer’s disease. J Int Neuropsychol Soc. 2002;8(6):753-63.
• 33. Paues BM, Krauel K. Chemosensory event-related potentials (CSERP) as a key to the psychology of odors. Int J Psychophysiol. 2000;36(2):105-22.